Literature DB >> 8464895

Kedarcidin chromophore: an enediyne that cleaves DNA in a sequence-specific manner.

N Zein1, K L Colson, J E Leet, D R Schroeder, W Solomon, T W Doyle, A M Casazza.   

Abstract

Kedarcidin chromophore is a 9-membered enediyne, recently isolated from an actinomycete strain. In vivo studies show this molecule to be extremely active against P388 leukemia and B16 melanoma. Cytotoxicity assays on the HCT116 colon carcinoma cell line result in an IC50 value of 1 nM. In vitro experiments with phi X174, pM2 DNA, and 32P-end-labeled restriction fragments demonstrate that this chromophore binds and cleaves duplex DNA with a remarkable sequence selectivity producing single-strand breaks. The cleavage chemistry requires reducing agents and oxygen similar to the other naturally occurring enediynes. Certain cations (Ca2+ and Mg2+) prevent strand cleavage. High-resolution 1H NMR studies on the chromophore in the presence of calcium chloride implicate the 2-hydroxynaphthoyl moiety in DNA binding. Interestingly, the kedarcidin chromophore appears structurally related to neocarzinostatin yet recognizes specific DNA sequences in a manner similar to calicheamicin gamma 1I, an enediyne with a significantly different structure. Moreover, kedarcidin and calicheamicin share a DNA preferred site, the TCCTN-mer. These observations indicate that the individual structural features of these agents are not solely responsible for their DNA selectivity. Rather, a complementarity between their overall tertiary structure and the local conformation of the DNA at the binding sites must play a significant role in the recognition process.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8464895      PMCID: PMC46188          DOI: 10.1073/pnas.90.7.2822

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Kedarcidin, a new chromoprotein antitumor antibiotic. II. Isolation, purification and physico-chemical properties.

Authors:  S J Hofstead; J A Matson; A R Malacko; H Marquardt
Journal:  J Antibiot (Tokyo)       Date:  1992-08       Impact factor: 2.649

2.  Mechanism of activation of the antitumor antibiotic neocarzinostatin by mercaptan and sodium borohydride.

Authors:  O D Hensens; I H Goldberg
Journal:  J Antibiot (Tokyo)       Date:  1989-05       Impact factor: 2.649

3.  Nucleotide-specific cleavage and minor-groove interaction of DNA with esperamicin antitumor antibiotics.

Authors:  Y Sugiura; Y Uesawa; Y Takahashi; J Kuwahara; J Golik; T W Doyle
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

4.  Crystallographic study of one turn of G/C-rich B-DNA.

Authors:  U Heinemann; C Alings
Journal:  J Mol Biol       Date:  1989-11-20       Impact factor: 5.469

5.  Sequence-specific isotope effects on the cleavage of DNA by bleomycin.

Authors:  J W Kozarich; L Worth; B L Frank; D F Christner; D E Vanderwall; J Stubbe
Journal:  Science       Date:  1989-09-22       Impact factor: 47.728

Review 6.  DNA and associated targets for drug design.

Authors:  L H Hurley
Journal:  J Med Chem       Date:  1989-09       Impact factor: 7.446

7.  Calicheamicin gamma 1I and DNA: molecular recognition process responsible for site-specificity.

Authors:  N Zein; M Poncin; R Nilakantan; G A Ellestad
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

8.  Dynemicin A, a novel antibiotic with the anthraquinone and 1,5-diyn-3-ene subunit.

Authors:  M Konishi; H Ohkuma; K Matsumoto; T Tsuno; H Kamei; T Miyaki; T Oki; H Kawaguchi; G D VanDuyne; J Clardy
Journal:  J Antibiot (Tokyo)       Date:  1989-09       Impact factor: 2.649

Review 9.  Free radical mechanisms in neocarzinostatin-induced DNA damage.

Authors:  I H Goldberg
Journal:  Free Radic Biol Med       Date:  1987       Impact factor: 7.376

10.  Esperamicins, a class of potent antitumor antibiotics: mechanism of action.

Authors:  B H Long; J Golik; S Forenza; B Ward; R Rehfuss; J C Dabrowiak; J J Catino; S T Musial; K W Brookshire; T W Doyle
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

View more
  7 in total

1.  Large scale production and semi-purification of kedarcidin in a 1000-L fermentor.

Authors:  K S Lam; D R Gustavson; J M Veitch; S Forenza; J Ross; D Miller; J Roach; W B Lebherz; K Poole
Journal:  J Ind Microbiol       Date:  1994-11

Review 2.  Astonishing diversity of natural surfactants: 6. Biologically active marine and terrestrial alkaloid glycosides.

Authors:  Valery M Dembitsky
Journal:  Lipids       Date:  2005-11       Impact factor: 1.880

3.  Synthesis of L-kedarosamine in protected form and its efficient incorporation into an advanced intermediate to kedarcidin chromophore.

Authors:  Feng Ren; Philip C Hogan; Alan J Anderson; Andrew G Myers
Journal:  Org Lett       Date:  2007-04-18       Impact factor: 6.005

4.  Regiospecific O-methylation of naphthoic acids catalyzed by NcsB1, an O-methyltransferase involved in the biosynthesis of the enediyne antitumor antibiotic neocarzinostatin.

Authors:  Yinggang Luo; Shuangjun Lin; Jian Zhang; Heather A Cooke; Steven D Bruner; Ben Shen
Journal:  J Biol Chem       Date:  2008-04-03       Impact factor: 5.157

5.  Selective proteolytic activity of the antitumor agent kedarcidin.

Authors:  N Zein; A M Casazza; T W Doyle; J E Leet; D R Schroeder; W Solomon; S G Nadler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

6.  Cloning and sequencing of the kedarcidin biosynthetic gene cluster from Streptoalloteichus sp. ATCC 53650 revealing new insights into biosynthesis of the enediyne family of antitumor antibiotics.

Authors:  Jeremy R Lohman; Sheng-Xiong Huang; Geoffrey P Horsman; Paul E Dilfer; Tingting Huang; Yihua Chen; Evelyn Wendt-Pienkowski; Ben Shen
Journal:  Mol Biosyst       Date:  2013-01-29

7.  Amino-Supported Palladium Catalyst for Chemo- and Stereoselective Domino Reactions.

Authors:  Man-Bo Li; Jie Yang; Ying Yang; Guo-Yong Xu; Gen Luo; Jianping Yang; Jan-E Bäckvall
Journal:  Angew Chem Int Ed Engl       Date:  2020-11-10       Impact factor: 16.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.